Lataa...
Commentary on ICH guideline on genomic sampling and data management‐enabling opportunities in drug development and patient treatment
The ability to benefit from knowledge of human genomic data in medicine has been anticipated since the sequencing of the human genome. That promise has experienced some degree of realization, particularly in oncology where biomarker‐specific clinical trials and patient treatment specific to the gene...
Tallennettuna:
| Julkaisussa: | Br J Clin Pharmacol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7373702/ https://ncbi.nlm.nih.gov/pubmed/32307727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14305 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|